The popular glucagon-like peptide-1 (GLP-1) receptor agonists known to help in weight loss as well as manage blood sugar can ...

Only two in five people taking GLP-1 medication were confident they would maintain their weight loss after stopping the ...

In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...

In 2020, West Virginia started a pilot program providing subsidies for GLP-1 weight loss drugs for state employees. It showed ...

The likes of Wegovy and Ozempic could reduce the risk of kidney deterioration and failure by a fifth, a major study found.

GLP-1 receptor agonists were originally developed for the treatment of type 2 diabetes, and later of obesity, but there is growing evidence that their benefits extend far beyond reductions in blood ...

The analysis also confirmed previous findings that the jabs could prevent heart problems, with treated patients 14% less ...

Allurion's new program uses artificial intelligence guidance to help patients adhere to a well-rounded diet and exercise ...

Shares of Hims & Hers are moving higher after President-elect Donald Trump nominated Dr. Marty Makary, a pancreatic surgeon at Johns ...

Amid ongoing concerns about the cost and supply of GLP-1s, a new study suggests that a wide swath of American adults would ...